What is the Impact Factor of Prostate Cancer?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Prostate Cancer is 1.80, ranking in quartile Q4 of Web of Science (ESCI).

Is Prostate Cancer indexed in Web of Science or Scopus?

Yes, Prostate Cancer is indexed in Web of Science (ESCI, Q4 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.602 (Q2) and an H-index of 17.

Who publishes Prostate Cancer and what is the Article Processing Charge (APC)?

Prostate Cancer is published by Hindawi Limited. The estimated Article Processing Charge (APC) is approximately $2,850 USD, subject to institutional waivers and corresponding author affiliations.

WoS ESCI Q4Scopus Q2SCImago #9,819Gold OA

Prostate Cancer

Identifier (ISSN):2090-3111(Print)/2090-312X(Online)

•

Publisher:Hindawi Limited

Clarivate JCR Index Advisory: Active (ESCI)

Official Website Submission Portal Compare

Clarivate IF (2026)

1.8↓ -0.2

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS ESCIJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for Prostate Cancer

WoS Q4

Annual Impact Factor Metric

Current (2026):1.8

Scopus SJR & RankScopus Q2

0.602

#9,819

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

17 papers with at least that number of citations each

WoS: ESCIQ4

Self-Citation Rate0%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessGold OA

7articles/year

100% Gold OA•77.78% Original Research

Aims & Scope

Prostate Cancer is a peer-reviewed, Open Access journal that provides a multidisciplinary platform for scientists, surgeons, oncologists and clinicians working on prostate cancer. The journal publishes original research articles, review articles, and clinical studies related to the diagnosis, surgery, radiotherapy, drug discovery and medical management of the disease.

Topics Covered (Recognized by AI)

Medicine99.5%Internal medicine98.9%Biology98.9%Genetics98.4%Prostate cancer98.4%Cancer98.4%Prostate74.5%Pathology65.4%Surgery46.3%Oncology39.9%Mathematics39.9%Chemistry38.3%Radiology35.1%Biochemistry34%Urology31.9%Statistics25%Prostatectomy23.9%Physics23.4%

Primary Research Areas

Oncology

Official Website NLM PubMed Catalog SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRESCI2026

ONCOLOGY

Rank264/333

IndexESCI

JCIESCI2026

ONCOLOGY

Rank296/333

IndexESCI

Category	Index	Rank	Quartile
ONCOLOGY	JCRESCI	264/333	Q4
ONCOLOGY	JCIESCI	296/333	Q4

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF1.8

Articles / Year10

Total Citations1

2025

IF2

Articles / Year13

Total Citations15

2024

IF2.3

Articles / Year26

Total Citations30

2023

IF4.2

Articles / Year2

Total Citations6

2022

IF—

Articles / Year10

Total Citations60

Year	Impact Factor	Articles / Year	Total Citations
2026	1.8	10	1
2025	2	13	15
2024	2.3	26	30
2023	4.2	2	6
2022	—	10	60
2021	—	24	218
2020	—	15	145
2019	—	12	208
2018	—	37	33
2017	—	3	79
2016	—	32	321
2015	—	81	314

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #9,819Scopus Q2SCImago Profile

Scopus Coverage:2010-2026

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine

Scopus Citation Rank (SJR)Q2

0.602

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2

Citations / Doc (2 years)

1.25

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$2,850 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations30

3-Year Documents17

Citable Documents17

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate29.8%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

UrologyQ2

Cancer ResearchQ3

OncologyQ3

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

4区 (Zone 4)Medicine

Minor Category (Specific Field):

4区ANDROLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Prostate Cancer (ISSN: 2090-3111) is a peer-reviewed international scholarly journal in the field of ONCOLOGY, published by Hindawi Limited in United Kingdom. The periodical holds a Journal Impact Factor (JIF) of 1.80, ranking in quartile Q4 of Web of Science (ESCI), a Scopus SJR indicator of 0.602 (Q2), an H-index of 17.

The journal enforces rigorous peer evaluation with an annual output of approximately 7 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $2,850 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.